Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia

Clin Nucl Med. 2005 Feb;30(2):105-6. doi: 10.1097/00003072-200502000-00008.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Artifacts*
  • Citrates* / pharmacokinetics
  • Diuretics / adverse effects
  • Diuretics / therapeutic use
  • Fluorodeoxyglucose F18* / pharmacokinetics
  • Gallium* / pharmacokinetics
  • Gynecomastia / chemically induced*
  • Gynecomastia / diagnostic imaging*
  • Gynecomastia / metabolism
  • Heart Failure / complications
  • Heart Failure / diagnostic imaging*
  • Heart Failure / drug therapy
  • Humans
  • Male
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Spironolactone / adverse effects*
  • Spironolactone / therapeutic use

Substances

  • Citrates
  • Diuretics
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Spironolactone
  • Gallium
  • gallium citrate